Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 2
2000 1
2001 1
2002 1
2004 1
2005 1
2006 5
2007 2
2008 3
2009 5
2010 7
2011 6
2012 9
2013 11
2014 9
2015 15
2016 12
2017 13
2018 13
2019 17
2020 19
2021 24
2022 24
2023 30
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Irie
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Theoretical and Experimental Investigations of Stable Arylfluorene-Based Radical-Type Mechanophores.
Sugita H, Lu Y, Aoki D, Otsuka H, Mikami K. Sugita H, et al. Chemistry. 2023 Feb 24;29(12):e202300230. doi: 10.1002/chem.202300230. Epub 2023 Feb 7. Chemistry. 2023. PMID: 36750889
Invited for the cover of this issue are the groups of Hideyuki Otsuka at the Tokyo Institute of Technology and Koichiro Mikami at the Sagami Chemical Research Institute. The image depicts theoretical and experimental investigations of stable arylfluorene-based radical-type …
Invited for the cover of this issue are the groups of Hideyuki Otsuka at the Tokyo Institute of Technology and Koichiro Mikami at the …
Ratchet syndrome.
Ejima K, Shoda M, Manaka T, Hagiwara N. Ejima K, et al. Intern Med. 2012;51(9):1139. doi: 10.2169/internalmedicine.51.7372. Epub 2012 Apr 29. Intern Med. 2012. PMID: 22576404 Free article. No abstract available.
Re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy Have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy.
Liedberg F, Abrahamsson J, Bobjer J. Liedberg F, et al. Eur Urol. 2022 Jan;81(1):e18-e19. doi: 10.1016/j.eururo.2021.10.007. Epub 2021 Oct 26. Eur Urol. 2022. PMID: 34716048 No abstract available.
Announcement: UEDA Heart Award for 2017.
[No authors listed] [No authors listed] Int Heart J. 2017;58(6):1034. doi: 10.1536/ihj.58-6_UEDA. Int Heart J. 2017. PMID: 29238012 Free article.
Naito, Jong-Kook Lee, Rika Kitazume-Taneike, Masamichi Ito, Toshihiro Yamaguchi, Ryo Nakata, Tomokazu Sumida, Katsuki Okada, Akito Nakagawa, Tomoaki Higo, Yuki Kuramoto, Taku Sakai, Koji Tominaga, Takeshi Okinaga, Shigetoyo Kogaki, Keiichi Ozono, Shigeru Miyagawa, Yoshiki Sawa, Y …
Naito, Jong-Kook Lee, Rika Kitazume-Taneike, Masamichi Ito, Toshihiro Yamaguchi, Ryo Nakata, Tomokazu Sumida, Katsuki Okada, Akito Nakagawa, …
Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma.
Shigeta K, Matsumoto K, Oya M. Shigeta K, et al. Eur Urol. 2022 Jan;81(1):e20-e21. doi: 10.1016/j.eururo.2021.10.008. Epub 2021 Oct 26. Eur Urol. 2022. PMID: 34716047 No abstract available.
National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study.
Kurogi R, Kada A, Ogasawara K, Nishimura K, Kitazono T, Iwama T, Matsumaru Y, Sakai N, Shiokawa Y, Miyachi S, Kuroda S, Shimizu H, Yoshimura S, Osato T, Horie N, Nagata I, Nozaki K, Date I, Hashimoto Y, Hoshino H, Nakase H, Kataoka H, Ohta T, Fukuda H, Tamiya N, Kurogi AI, Ren N, Nishimura A, Arimura K, Shimogawa T, Yoshimoto K, Onozuka D, Ogata S, Hagihara A, Saito N, Arai H, Miyamoto S, Tominaga T, Iihara K; J-ASPECT Study Collaborators. Kurogi R, et al. BMJ Open. 2023 Apr 10;13(4):e068642. doi: 10.1136/bmjopen-2022-068642. BMJ Open. 2023. PMID: 37037619 Free PMC article.
208 results